The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Teriflunomide Market Research Report 2025
Synopsis
Teriflunomide is an active metabolite of Leflunomide. It inhibits the synthesis of pyrimidine by inhibiting the enzyme dihydroorotate dehydrogenase, as an immunomodulator.
The global Teriflunomide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Teriflunomide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Teriflunomide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Teriflunomide include Sanofi Aventis, Genzyme Corporation, Amneal Pharmaceuticals NY LC, Glenmark Pharmaceuticals and Msn Laboratories Private Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Teriflunomide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Teriflunomide.
Report Scope
The Teriflunomide market size, estimations, and forecasts are provided in terms of sales volume (Kilograms) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Teriflunomide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Teriflunomide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Aventis
Genzyme Corporation
Amneal Pharmaceuticals NY LC
Glenmark Pharmaceuticals
Msn Laboratories Private Limited
Segment by Type
Tablets
Powder
Segment by Application
Immunosuppression
Cancer Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Teriflunomide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Teriflunomide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Teriflunomide is an active metabolite of Leflunomide. It inhibits the synthesis of pyrimidine by inhibiting the enzyme dihydroorotate dehydrogenase, as an immunomodulator.
The global Teriflunomide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Teriflunomide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Teriflunomide is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Teriflunomide include Sanofi Aventis, Genzyme Corporation, Amneal Pharmaceuticals NY LC, Glenmark Pharmaceuticals and Msn Laboratories Private Limited, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Teriflunomide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Teriflunomide.
Report Scope
The Teriflunomide market size, estimations, and forecasts are provided in terms of sales volume (Kilograms) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Teriflunomide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Teriflunomide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi Aventis
Genzyme Corporation
Amneal Pharmaceuticals NY LC
Glenmark Pharmaceuticals
Msn Laboratories Private Limited
Segment by Type
Tablets
Powder
Segment by Application
Immunosuppression
Cancer Treatment
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Teriflunomide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Teriflunomide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Teriflunomide Market Overview
1.1 Product Overview and Scope of Teriflunomide
1.2 Teriflunomide Segment by Type
1.2.1 Global Teriflunomide Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Powder
1.3 Teriflunomide Segment by Application
1.3.1 Global Teriflunomide Market Value by Application: (2024-2030)
1.3.2 Immunosuppression
1.3.3 Cancer Treatment
1.4 Global Teriflunomide Market Size Estimates and Forecasts
1.4.1 Global Teriflunomide Revenue 2019-2030
1.4.2 Global Teriflunomide Sales 2019-2030
1.4.3 Global Teriflunomide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Teriflunomide Market Competition by Manufacturers
2.1 Global Teriflunomide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Teriflunomide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Teriflunomide Average Price by Manufacturers (2019-2024)
2.4 Global Teriflunomide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Teriflunomide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Teriflunomide, Product Type & Application
2.7 Teriflunomide Market Competitive Situation and Trends
2.7.1 Teriflunomide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Teriflunomide Players Market Share by Revenue
2.7.3 Global Teriflunomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Teriflunomide Retrospective Market Scenario by Region
3.1 Global Teriflunomide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Teriflunomide Global Teriflunomide Sales by Region: 2019-2030
3.2.1 Global Teriflunomide Sales by Region: 2019-2024
3.2.2 Global Teriflunomide Sales by Region: 2025-2030
3.3 Global Teriflunomide Global Teriflunomide Revenue by Region: 2019-2030
3.3.1 Global Teriflunomide Revenue by Region: 2019-2024
3.3.2 Global Teriflunomide Revenue by Region: 2025-2030
3.4 North America Teriflunomide Market Facts & Figures by Country
3.4.1 North America Teriflunomide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Teriflunomide Sales by Country (2019-2030)
3.4.3 North America Teriflunomide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Teriflunomide Market Facts & Figures by Country
3.5.1 Europe Teriflunomide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Teriflunomide Sales by Country (2019-2030)
3.5.3 Europe Teriflunomide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Teriflunomide Market Facts & Figures by Country
3.6.1 Asia Pacific Teriflunomide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Teriflunomide Sales by Country (2019-2030)
3.6.3 Asia Pacific Teriflunomide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Teriflunomide Market Facts & Figures by Country
3.7.1 Latin America Teriflunomide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Teriflunomide Sales by Country (2019-2030)
3.7.3 Latin America Teriflunomide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Teriflunomide Market Facts & Figures by Country
3.8.1 Middle East and Africa Teriflunomide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Teriflunomide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Teriflunomide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Teriflunomide Sales by Type (2019-2030)
4.1.1 Global Teriflunomide Sales by Type (2019-2024)
4.1.2 Global Teriflunomide Sales by Type (2025-2030)
4.1.3 Global Teriflunomide Sales Market Share by Type (2019-2030)
4.2 Global Teriflunomide Revenue by Type (2019-2030)
4.2.1 Global Teriflunomide Revenue by Type (2019-2024)
4.2.2 Global Teriflunomide Revenue by Type (2025-2030)
4.2.3 Global Teriflunomide Revenue Market Share by Type (2019-2030)
4.3 Global Teriflunomide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Teriflunomide Sales by Application (2019-2030)
5.1.1 Global Teriflunomide Sales by Application (2019-2024)
5.1.2 Global Teriflunomide Sales by Application (2025-2030)
5.1.3 Global Teriflunomide Sales Market Share by Application (2019-2030)
5.2 Global Teriflunomide Revenue by Application (2019-2030)
5.2.1 Global Teriflunomide Revenue by Application (2019-2024)
5.2.2 Global Teriflunomide Revenue by Application (2025-2030)
5.2.3 Global Teriflunomide Revenue Market Share by Application (2019-2030)
5.3 Global Teriflunomide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi Aventis
6.1.1 Sanofi Aventis Corporation Information
6.1.2 Sanofi Aventis Description and Business Overview
6.1.3 Sanofi Aventis Teriflunomide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Aventis Teriflunomide Product Portfolio
6.1.5 Sanofi Aventis Recent Developments/Updates
6.2 Genzyme Corporation
6.2.1 Genzyme Corporation Corporation Information
6.2.2 Genzyme Corporation Description and Business Overview
6.2.3 Genzyme Corporation Teriflunomide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Genzyme Corporation Teriflunomide Product Portfolio
6.2.5 Genzyme Corporation Recent Developments/Updates
6.3 Amneal Pharmaceuticals NY LC
6.3.1 Amneal Pharmaceuticals NY LC Corporation Information
6.3.2 Amneal Pharmaceuticals NY LC Description and Business Overview
6.3.3 Amneal Pharmaceuticals NY LC Teriflunomide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Amneal Pharmaceuticals NY LC Teriflunomide Product Portfolio
6.3.5 Amneal Pharmaceuticals NY LC Recent Developments/Updates
6.4 Glenmark Pharmaceuticals
6.4.1 Glenmark Pharmaceuticals Corporation Information
6.4.2 Glenmark Pharmaceuticals Description and Business Overview
6.4.3 Glenmark Pharmaceuticals Teriflunomide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Glenmark Pharmaceuticals Teriflunomide Product Portfolio
6.4.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.5 Msn Laboratories Private Limited
6.5.1 Msn Laboratories Private Limited Corporation Information
6.5.2 Msn Laboratories Private Limited Description and Business Overview
6.5.3 Msn Laboratories Private Limited Teriflunomide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Msn Laboratories Private Limited Teriflunomide Product Portfolio
6.5.5 Msn Laboratories Private Limited Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Teriflunomide Industry Chain Analysis
7.2 Teriflunomide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Teriflunomide Production Mode & Process
7.4 Teriflunomide Sales and Marketing
7.4.1 Teriflunomide Sales Channels
7.4.2 Teriflunomide Distributors
7.5 Teriflunomide Customers
8 Teriflunomide Market Dynamics
8.1 Teriflunomide Industry Trends
8.2 Teriflunomide Market Drivers
8.3 Teriflunomide Market Challenges
8.4 Teriflunomide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Teriflunomide Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Teriflunomide Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Teriflunomide Market Competitive Situation by Manufacturers in 2023
Table 4. Global Teriflunomide Sales (Kilograms) of Key Manufacturers (2019-2024)
Table 5. Global Teriflunomide Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Teriflunomide Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Teriflunomide Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Teriflunomide Average Price (US$/mg) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Teriflunomide, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Teriflunomide, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Teriflunomide, Product Type & Application
Table 12. Global Key Manufacturers of Teriflunomide, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Teriflunomide by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Teriflunomide as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Teriflunomide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Teriflunomide Sales by Region (2019-2024) & (Kilograms)
Table 18. Global Teriflunomide Sales Market Share by Region (2019-2024)
Table 19. Global Teriflunomide Sales by Region (2025-2030) & (Kilograms)
Table 20. Global Teriflunomide Sales Market Share by Region (2025-2030)
Table 21. Global Teriflunomide Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Teriflunomide Revenue Market Share by Region (2019-2024)
Table 23. Global Teriflunomide Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Teriflunomide Revenue Market Share by Region (2025-2030)
Table 25. North America Teriflunomide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Teriflunomide Sales by Country (2019-2024) & (Kilograms)
Table 27. North America Teriflunomide Sales by Country (2025-2030) & (Kilograms)
Table 28. North America Teriflunomide Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Teriflunomide Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Teriflunomide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Teriflunomide Sales by Country (2019-2024) & (Kilograms)
Table 32. Europe Teriflunomide Sales by Country (2025-2030) & (Kilograms)
Table 33. Europe Teriflunomide Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Teriflunomide Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Teriflunomide Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Teriflunomide Sales by Region (2019-2024) & (Kilograms)
Table 37. Asia Pacific Teriflunomide Sales by Region (2025-2030) & (Kilograms)
Table 38. Asia Pacific Teriflunomide Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Teriflunomide Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Teriflunomide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Teriflunomide Sales by Country (2019-2024) & (Kilograms)
Table 42. Latin America Teriflunomide Sales by Country (2025-2030) & (Kilograms)
Table 43. Latin America Teriflunomide Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Teriflunomide Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Teriflunomide Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Teriflunomide Sales by Country (2019-2024) & (Kilograms)
Table 47. Middle East & Africa Teriflunomide Sales by Country (2025-2030) & (Kilograms)
Table 48. Middle East & Africa Teriflunomide Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Teriflunomide Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Teriflunomide Sales (Kilograms) by Type (2019-2024)
Table 51. Global Teriflunomide Sales (Kilograms) by Type (2025-2030)
Table 52. Global Teriflunomide Sales Market Share by Type (2019-2024)
Table 53. Global Teriflunomide Sales Market Share by Type (2025-2030)
Table 54. Global Teriflunomide Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Teriflunomide Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Teriflunomide Revenue Market Share by Type (2019-2024)
Table 57. Global Teriflunomide Revenue Market Share by Type (2025-2030)
Table 58. Global Teriflunomide Price (US$/mg) by Type (2019-2024)
Table 59. Global Teriflunomide Price (US$/mg) by Type (2025-2030)
Table 60. Global Teriflunomide Sales (Kilograms) by Application (2019-2024)
Table 61. Global Teriflunomide Sales (Kilograms) by Application (2025-2030)
Table 62. Global Teriflunomide Sales Market Share by Application (2019-2024)
Table 63. Global Teriflunomide Sales Market Share by Application (2025-2030)
Table 64. Global Teriflunomide Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Teriflunomide Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Teriflunomide Revenue Market Share by Application (2019-2024)
Table 67. Global Teriflunomide Revenue Market Share by Application (2025-2030)
Table 68. Global Teriflunomide Price (US$/mg) by Application (2019-2024)
Table 69. Global Teriflunomide Price (US$/mg) by Application (2025-2030)
Table 70. Sanofi Aventis Corporation Information
Table 71. Sanofi Aventis Description and Business Overview
Table 72. Sanofi Aventis Teriflunomide Sales (Kilograms), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 73. Sanofi Aventis Teriflunomide Product
Table 74. Sanofi Aventis Recent Developments/Updates
Table 75. Genzyme Corporation Corporation Information
Table 76. Genzyme Corporation Description and Business Overview
Table 77. Genzyme Corporation Teriflunomide Sales (Kilograms), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 78. Genzyme Corporation Teriflunomide Product
Table 79. Genzyme Corporation Recent Developments/Updates
Table 80. Amneal Pharmaceuticals NY LC Corporation Information
Table 81. Amneal Pharmaceuticals NY LC Description and Business Overview
Table 82. Amneal Pharmaceuticals NY LC Teriflunomide Sales (Kilograms), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 83. Amneal Pharmaceuticals NY LC Teriflunomide Product
Table 84. Amneal Pharmaceuticals NY LC Recent Developments/Updates
Table 85. Glenmark Pharmaceuticals Corporation Information
Table 86. Glenmark Pharmaceuticals Description and Business Overview
Table 87. Glenmark Pharmaceuticals Teriflunomide Sales (Kilograms), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 88. Glenmark Pharmaceuticals Teriflunomide Product
Table 89. Glenmark Pharmaceuticals Recent Developments/Updates
Table 90. Msn Laboratories Private Limited Corporation Information
Table 91. Msn Laboratories Private Limited Description and Business Overview
Table 92. Msn Laboratories Private Limited Teriflunomide Sales (Kilograms), Revenue (US$ Million), Price (US$/mg) and Gross Margin (2019-2024)
Table 93. Msn Laboratories Private Limited Teriflunomide Product
Table 94. Msn Laboratories Private Limited Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Teriflunomide Distributors List
Table 98. Teriflunomide Customers List
Table 99. Teriflunomide Market Trends
Table 100. Teriflunomide Market Drivers
Table 101. Teriflunomide Market Challenges
Table 102. Teriflunomide Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Teriflunomide
Figure 2. Global Teriflunomide Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Teriflunomide Market Share by Type in 2023 & 2030
Figure 4. Tablets Product Picture
Figure 5. Powder Product Picture
Figure 6. Global Teriflunomide Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Teriflunomide Market Share by Application in 2023 & 2030
Figure 8. Immunosuppression
Figure 9. Cancer Treatment
Figure 10. Global Teriflunomide Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Teriflunomide Market Size (2019-2030) & (US$ Million)
Figure 12. Global Teriflunomide Sales (2019-2030) & (Kilograms)
Figure 13. Global Teriflunomide Average Price (US$/mg) & (2019-2030)
Figure 14. Teriflunomide Report Years Considered
Figure 15. Teriflunomide Sales Share by Manufacturers in 2023
Figure 16. Global Teriflunomide Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Teriflunomide Players: Market Share by Revenue in 2023
Figure 18. Teriflunomide Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Teriflunomide Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Teriflunomide Sales Market Share by Country (2019-2030)
Figure 21. North America Teriflunomide Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Teriflunomide Sales Market Share by Country (2019-2030)
Figure 25. Europe Teriflunomide Revenue Market Share by Country (2019-2030)
Figure 26. Germany Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Teriflunomide Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Teriflunomide Revenue Market Share by Region (2019-2030)
Figure 33. China Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Teriflunomide Sales Market Share by Country (2019-2030)
Figure 44. Latin America Teriflunomide Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Teriflunomide Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Teriflunomide Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Teriflunomide Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Teriflunomide by Type (2019-2030)
Figure 54. Global Revenue Market Share of Teriflunomide by Type (2019-2030)
Figure 55. Global Teriflunomide Price (US$/mg) by Type (2019-2030)
Figure 56. Global Sales Market Share of Teriflunomide by Application (2019-2030)
Figure 57. Global Revenue Market Share of Teriflunomide by Application (2019-2030)
Figure 58. Global Teriflunomide Price (US$/mg) by Application (2019-2030)
Figure 59. Teriflunomide Value Chain
Figure 60. Teriflunomide Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
